Viewing SEC Facts Units
Company Name:
Portola Pharmaceuticals, Inc.
CIK:
1269021
Start Filing Date:
2019-04-01
End Filing Date:
2019-06-30
ACCN:
0001564590-19-030122
Value:
$ 68,128,238
Value Error:
$ None
Created By:
Date Filed:
2019-08-07
FY:
2019
Fiscal Period:
Q2
Frame:
CY2019Q2
Type:
us-gaap
Form:
10-Q
Units:
shares